Product Information

NEOMYC-POLYM-GRAMICID EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $4.6471 per ML under NDC 24208079062. Its NADAC has been published 626 times since Nov 28, 2013.

FDA first approved this application on Jan 31, 1996. Its Orange Book therapeutic-equivalence code is AT.

NEOMYC-POLYM-GRAMICID EYE DROP

neomycin sulfate, polymyxin b sulfate and gramicidin
$4.6471per ML

Strength

.025; 1.75; 10000 mg/mL; mg/mL; [USP'U]/mL

NDC

24208079062

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA064047

FDA Approved

1/31/1996

TE Code

AT

On Market Since

1/31/1996

Pharmacological Classes

Price Statistics

The NADAC for NEOMYC-POLYM-GRAMICID EYE DROP has been published 626 times since Nov 28, 2013, and over the history we have for it it has risen 7.5%. The table below summarizes its recorded NADAC range and movement.

Current price$4.6471 per ML
All-time high$5.0002 (Aug 16, 2017)
All-time low$3.7458 (Jul 17, 2024)
52-week high$4.7341
52-week low$4.2473
Median price$4.5629
Average price$4.5156
Largest weekly change-15.6% (Apr 18, 2018)
Weeks tracked626
Tracking sinceNov 28, 2013

Price History

1W

-1.8%

1M

-1.8%

3M

+1.5%

6M

+7.4%

1Y

+4.0%

3Y

-1.7%

5Y

-3.6%

All

+7.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the neomycin sulfate, polymyxin b sulfate and gramicidin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of NEOMYC-POLYM-GRAMICID EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for NEOMYC-POLYM-GRAMICID EYE DROP, manufactured by Bausch & Lomb Incorporated, is $4.6471 per ML (NDC 24208079062), effective Aug 19, 2026.

How has the price of NEOMYC-POLYM-GRAMICID EYE DROP changed over time?

Over the history we have for it, the NADAC for NEOMYC-POLYM-GRAMICID EYE DROP has risen 7.5%. It has been tracked across 626 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NEOMYC-POLYM-GRAMICID EYE DROP?

Since Nov 28, 2013, the NADAC for NEOMYC-POLYM-GRAMICID EYE DROP has ranged from a low of $3.7458 (Jul 17, 2024) to a high of $5.0002 (Aug 16, 2017), with a median of $4.5629 per ML.

Are there cheaper alternatives to NEOMYC-POLYM-GRAMICID EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of NEOMYC-POLYM-GRAMICID EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NEOMYC-POLYM-GRAMICID EYE DROP?

NEOMYC-POLYM-GRAMICID EYE DROP (NDC 24208079062) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.